Cargando…

Immunogenicity Studies of Bivalent Inactivated Virions of EV71/CVA16 Formulated with Submicron Emulsion Systems

We assessed two strategies for preparing candidate vaccines against hand, foot, and mouth disease (HFMD) caused mainly by infections of enterovirus (EV) 71 and coxsackievirus (CV) A16. We firstly design and optimize the potency of adjuvant combinations of emulsion-based delivery systems, using EV71...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chih-Wei, Liu, Chia-Chyi, Lu, Tsung-Chun, Liu, Shih-Jen, Chow, Yen-Hung, Chong, Pele, Huang, Ming-Hsi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071850/ https://www.ncbi.nlm.nih.gov/pubmed/25006583 http://dx.doi.org/10.1155/2014/670506

Ejemplares similares

Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques
por: Liu, Chia-Chyi, et al.
Publicado: (2014)

Global Gene Expression Analysis of the Brainstem in EV71- and CVA16-Infected Gerbils
por: Sun, Yi-Sheng, et al.
Publicado: (2019)

The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus
por: Wu, Chia-Ying, et al.
Publicado: (2019)

Production of EV71 vaccine candidates
por: Chong, Pele, et al.
Publicado: (2012)

Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy
por: Wang, Huiqiang, et al.
Publicado: (2019)

Human SCARB2-Mediated Entry and Endocytosis of EV71
por: Lin, Yi-Wen, et al.
Publicado: (2012)

Preclinical safety evaluation of a bivalent inactivated EV71-CA16 vaccine in mice immunized intradermally
por: Liao, Yun, et al.
Publicado: (2023)

Comparative Analysis of the Immunogenicity and Protective Effects of Inactivated EV71 Vaccines in Mice
por: Mao, Qunying, et al.
Publicado: (2012)

Delivery of Human EV71 Receptors by Adeno-Associated Virus Increases EV71 Infection-Induced Local Inflammation in Adult Mice
por: Hsiao, Hung-Bo, et al.
Publicado: (2014)

Recombination in the Evolution of Enterovirus C Species Sub-Group that Contains Types CVA-21, CVA-24, EV-C95, EV-C96 and EV-C99
por: Smura, Teemu, et al.
Publicado: (2014)

The Evolution of Vp1 Gene in Enterovirus C Species Sub-Group That Contains Types CVA-21, CVA-24, EV-C95, EV-C96 and EV-C99
por: Smura, Teemu, et al.
Publicado: (2014)

Immunological Evaluation and Comparison of Different EV71 Vaccine Candidates
por: Chou, Ai-Hsiang, et al.
Publicado: (2012)

Etiology of Multiple Non-EV71 and Non-CVA16 Enteroviruses Associated with Hand, Foot and Mouth Disease in Jinan, China, 2009—June 2013
por: Guan, Hengyun, et al.
Publicado: (2015)

The uncoating of EV71 in mature late endosomes requires CD-M6PR
por: Ohka, Seii, et al.
Publicado: (2022)

Induction of SOCS Expression by EV71 Infection Promotes EV71 Replication
por: Gao, Wenying, et al.
Publicado: (2020)

Study of the Integrated Immune Response Induced by an Inactivated EV71 Vaccine
por: Liu, Longding, et al.
Publicado: (2013)

Serotyping and Genetic Characterization of Hand, Foot, and Mouth Disease (HFMD)-Associated Enteroviruses of No-EV71 and Non-CVA16 Circulating in Fujian, China, 2011–2015
por: Weng, Yuwei, et al.
Publicado: (2017)

Progress on the research and development of inactivated EV71 whole-virus vaccines
por: Liang, Zheng-Lun, et al.
Publicado: (2013)

Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection
por: Chang, Guo-hui, et al.
Publicado: (2010)

Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine
por: Montalban, Cecilia, et al.
Publicado: (2017)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
por: Chen, Yaping, et al.
Publicado: (2022)

Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)
por: Victorio, Carla Bianca Luena, et al.
Publicado: (2014)

Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

Formalin-Inactivated EV71 Vaccine Candidate Induced Cross-Neutralizing Antibody against Subgenotypes B1, B4, B5 and C4A in Adult Volunteers
por: Chou, Ai-Hsiang, et al.
Publicado: (2013)

Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1
por: Tan, Chee Wah, et al.
Publicado: (2012)

A Bivalent Inactivated Vaccine Prevents Enterovirus 71 and Coxsackievirus A16 Infections in the Mongolian Gerbil
por: Yi, Eun-Je, et al.
Publicado: (2023)

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)

Protective effect of enterovirus-71 (EV71) virus-like particle vaccine against lethal EV71 infection in a neonatal mouse model
por: CAO, LEI, et al.
Publicado: (2015)

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine
por: Hwa, Shi-Hsia, et al.
Publicado: (2013)

EV71 vaccine, an invaluable gift for children
por: Liang, Zhenglun, et al.
Publicado: (2014)

A clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema
por: Victorio, Carla Bianca Luena, et al.
Publicado: (2016)

Simultaneous enterovirus EV-D68 and CVA6 infections causing acute respiratory distress syndrome and hand, foot and mouth disease
por: de Sousa, Ivanildo Pedro, et al.
Publicado: (2021)

Ponatinib-Induced Cerebrovascular Accident (CVA)
por: Azad, Farhan, et al.
Publicado: (2022)

Effects of Process and Formulation Parameters on Submicron Polymeric Particles Produced by a Rapid Emulsion-Diffusion Method
por: Domínguez-Delgado, Clara Luisa, et al.
Publicado: (2022)

Correction: Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)
Publicado: (2014)

Inhibition of EV71 by curcumin in intestinal epithelial cells
por: Huang, Hsing-I, et al.
Publicado: (2018)

Exosomes cloak the virion to transmit Enterovirus 71 non-lytically
por: Gu, Jiaqi, et al.
Publicado: (2019)

EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge
por: Wang, Xiaowen, et al.
Publicado: (2016)

Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
por: Zhang, Zhegang, et al.
Publicado: (2022)

Evaluation of Neuroprtective Effects of L-Carnitine and Fat Emulsion in the CVA Patients: A Prospective, Randomized, Double Blind, Clinical Trial
por: Kazemian, Kaveh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f0ul8i2qi3reatb20k6tfdtdn9